ArticleCancers2026

Residual Platinum-Induced Neuropathy and the Feasibility of Second-Line Paclitaxel-Ramucirumab Therapy in Advanced Gastric Cancer: Prospective Multicenter Evidence from Japan.

Takeshi Nagasaka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.